10x Genomics, Inc. (TXG)

NASDAQ: TXG · Real-Time Price · USD

69.86

-2.53 (-3.49%)

At close: Oct 16, 2026, 4:00 PM EDT

69.46

-0.40 (-0.57%)

After-hours: Oct 16, 2026, 7:34 PM EDT

10x Genomics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-75.13	-43.54	-182.63	-255.1	-166	-58.22
Depreciation & Amortization	47.6	43.82	43.71	43.62	33.01	28.25
Asset Writedown & Restructuring Costs	0.7	0.81	3.05	9.85	-	-
Loss (Gain) From Sale of Investments	-	-	0	1.72	-	-
Stock-Based Compensation	98.74	109.12	140.75	166.95	136.85	95.96
Other Operating Activities	3.59	0.91	0.52	0.43	1.96	0.08
Change in Accounts Receivable	2.86	41.31	26.95	-10.61	-18.95	-34.04
Change in Inventory	18.57	27.95	-9.78	7.87	-21.19	-30.13
Change in Accounts Payable	2.46	-2.13	-3.35	-6.02	5.86	11.08
Change in Unearned Revenue	-0.31	0.75	11.21	10.93	3.35	1.54
Change in Other Net Operating Assets	27.99	-42.95	-23.78	15.17	-8.49	-35.89
Operating Cash Flow	127.09	136.05	6.66	-15.2	-33.61	-21.37
Operating Cash Flow Growth	89.81%	1941.57%	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-5.65	-5.94	-12.39	-48.6	-131.66	-101.28
Cash Acquisitions	-15.37	-9.27	-	-	-4	-5.45
Sale (Purchase) of Intangibles	-	-	-1	-0.92	-	-
Investment in Securities	1.37	1.77	-19.24	183.02	-215.23	-
Investing Cash Flow	-19.65	-13.44	-32.63	133.49	-350.89	-106.73

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Repaid	-	-	-	-5.81	-5.41	-5.03
Total Debt Repaid	-	-	-	-5.81	-5.41	-5.03
Net Debt Issued (Repaid)	-	-	-	-5.81	-5.41	-5.03
Issuance of Common Stock	6.15	6.8	10.91	19.48	21.23	40.33
Financing Cash Flow	-2.54	6.8	10.91	13.67	15.82	35.3

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.09	0.48	-0.16	-0.03	-0.04	0.23
Net Cash Flow	104.8	129.9	-15.22	131.93	-368.72	-92.57

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	121.44	130.12	-5.73	-63.8	-165.27	-122.65
Free Cash Flow Growth	113.51%	-	-	-	-	-
Free Cash Flow Margin	19.68%	20.24%	-0.94%	-10.31%	-32.00%	-25.01%
Free Cash Flow Per Share	0.95	1.04	-0.05	-0.55	-1.45	-1.11
Levered Free Cash Flow	179.66	148.39	59.2	27.63	-92.66	-67.02
Unlevered Free Cash Flow	179.66	148.39	59.2	27.65	-92.36	-66.48

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash Interest Paid	-	-	-	0.44	0.84	1.22
Cash Income Tax Paid	2.02	2.39	5.64	4.93	3.93	8.66
Change in Working Capital	51.58	24.94	1.25	17.34	-39.42	-87.45

SEC Filings: 10-K · 10-Q